Intelligent Investor

Melbana Energy Limited (ASX: MAY) - Announcements

Current share price for MAY : $0.058 0.001 (1.69%)

ASX company news and announcements for Melbana Energy Limited (MAY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Melbana Energy Limited (MAY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Melbana Energy Limited (MAY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Melbana Energy Limited (MAY)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$195 Acq specialist pharmaceutical manufacturing bus in Europe 3 May 2004 9:38AM $3.200 $0.058 $0.059 fallen by 98.19%
$195 Acq specialist pharmaceutical manufacturing bus in Europe 3 May 2004 9:38AM $3.200 $0.058 $0.059 fallen by 98.19%
$195 Update regarding Maynes pharmacy services business 20 Apr 2004 8:52AM $3.320 $0.058 $0.059 fallen by 98.25%
$195 Update regarding Maynes pharmacy services business 20 Apr 2004 8:52AM $3.320 $0.058 $0.059 fallen by 98.25%
$195 Final Share Buy-Back Notice 22 Mar 2004 5:46PM $3.410 $0.058 $0.059 fallen by 98.30%
$195 Successfully completes off-market share buy-back 22 Mar 2004 9:14AM $3.470 $0.058 $0.059 fallen by 98.33%
$195 Acquisition of Injectable Multivitamin Suite of Products 1 Mar 2004 10:15AM $3.210 $0.058 $0.059 fallen by 98.19%
$195 Acquisition of Injectable Multivitamin Suite of Products 1 Mar 2004 10:15AM $3.210 $0.058 $0.059 fallen by 98.19%
$195 Half Yearly Report/Half Year Accounts/Information Compendium 25 Feb 2004 8:43AM $3.210 $0.058 $0.059 fallen by 98.19%
$195 Off-Market Share Buy-Back 30 Jan 2004 9:39AM $3.200 $0.058 $0.059 fallen by 98.19%
$195 Continuation of on-market buy-back 23 Dec 2003 5:04PM $3.200 $0.058 $0.059 fallen by 98.19%
$195 To invest $60m in pharmaceutical manufacturing sites 17 Dec 2003 9:19AM $3.310 $0.058 $0.059 fallen by 98.25%
$195 Completes Paclitaxel Purchase with NaPro 15 Dec 2003 9:39AM $3.350 $0.058 $0.059 fallen by 98.27%
$195 Completes Paclitaxel Purchase with NaPro 15 Dec 2003 9:39AM $3.350 $0.058 $0.059 fallen by 98.27%
$195 Media Release: Tentative FDA approval of Fluconazole 9 Dec 2003 9:37AM $3.380 $0.058 $0.059 fallen by 98.28%
$195 Media Release: Hospitals sale update & buy-back intention 2 Dec 2003 9:21AM $3.540 $0.058 $0.059 fallen by 98.36%
$195 Development of New Laboratory for QML 28 Nov 2003 9:39AM $3.550 $0.058 $0.059 fallen by 98.37%
$195 Development of New Laboratory for QML 28 Nov 2003 9:39AM $3.550 $0.058 $0.059 fallen by 98.37%
$195 Purchases Oncology Drugs for the US market 30 Oct 2003 9:18AM $3.650 $0.058 $0.059 fallen by 98.41%
$195 Finalises agreement for sale of Hospitals business 21 Oct 2003 8:30AM $3.530 $0.058 $0.059 fallen by 98.36%
$195 Extension of Buy Back Program 1 Oct 2003 10:54AM $3.160 $0.058 $0.059 fallen by 98.16%
$195 Mayne Sells WA Diagnostic Imaging Assets 12 Sep 2003 5:28PM $3.430 $0.058 $0.059 fallen by 98.31%
$195 Preliminary Final Report 27 Aug 2003 8:30AM $3.300 $0.058 $0.059 fallen by 98.24%
$195 To acquire worldwide paclitaxel business 26 Aug 2003 2:29PM $3.400 $0.058 $0.059 fallen by 98.29%
$195 Acquires Melbourne Ultrasound for Women 24 Jun 2003 9:14AM $2.760 $0.058 $0.059 fallen by 97.90%

551 - 575 of 575 results

Page 23 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.